Norflex and Keratitis sicca - a phase IV clinical study of FDA data
Keratitis sicca is reported only by a few people who take Norflex.
The phase IV clinical study analyzes which people take Norflex and have Keratitis sicca. It is created by eHealthMe based on reports of 1,642 people who have side effects while taking Norflex from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,642 people reported to have side effects when taking Norflex.
Among them, 1 person (0.06%) has Keratitis sicca.
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,832 Norflex users for its effectiveness, alternative drugs and more.
What is Keratitis sicca?
Keratitis sicca (inflammation of the conjunctiva and cornea of the eye with decreased tears) is found to be associated with 888 drugs and 617 conditions by eHealthMe.
Number of Norflex and Keratitis sicca reports submitted per year:
Gender of people who have Keratitis sicca when taking Norflex *:
- female: 0.0 %
- male: 100 %
Age of people who have Keratitis sicca when taking Norflex *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs people take besides Norflex *:
- Valium: 1 person, 100.00%
- Toradol: 1 person, 100.00%
- Reglan: 1 person, 100.00%
- Prilosec: 1 person, 100.00%
- Prevacid: 1 person, 100.00%
- Percocet: 1 person, 100.00%
- Morphine: 1 person, 100.00%
- Medrol: 1 person, 100.00%
- Lorazepam: 1 person, 100.00%
- Combivent: 1 person, 100.00%
Common side effects people have besides Keratitis sicca *:
- Weight Decreased: 1 person, 100.00%
- Flat Affect (absence of emotional response to a situation): 1 person, 100.00%
- Dizziness: 1 person, 100.00%
- Drowsiness: 1 person, 100.00%
- Erection Problems: 1 person, 100.00%
- Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 100.00%
- Eye Irritation: 1 person, 100.00%
- Fainting (loss of consciousness and postural tone): 1 person, 100.00%
- Fall: 1 person, 100.00%
- Gingival Pain (gum pain): 1 person, 100.00%
Common conditions people have *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Norflex and have Keratitis sicca?Check whether Keratitis sicca is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keratitis sicca and when was it recovered:
Expand to all the drugs that have ingredients of orphenadrine citrate:
Alternative drugs to, pros and cons of Norflex:
- Norflex (1,832 reports)
Common Norflex side effects:
Browse all side effects of Norflex:a b c d e f g h i j k l m n o p q r s t u v w x y z
Keratitis sicca treatments and more:
- Keratitis sicca (1,435 reports)
COVID vaccines that are related to Keratitis sicca:
- Keratitis sicca in Moderna COVID Vaccine
- Keratitis sicca in Pfizer BioNTech Covid Vaccine
- Keratitis sicca in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keratitis sicca:
- Keratitis sicca (888 drugs)
All the conditions that are associated with Keratitis sicca:
- Keratitis sicca (617 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Modafinil and Linaclotide drug interaction - now
- Mavyret and Amlodipine drug interaction - a second ago
- Zolpidem Tartrate and Cardioactive Drug Level Increased - 12 seconds ago
- Hyperthyroidism and Gingivitis - 17 seconds ago
- Naloxone and Nasopharyngitis - 21 seconds ago
- Garlic and Joint Stiffness - 21 seconds ago
- Evista and Cardiac Valve Disease - 22 seconds ago
- Nexavar and Metabolic Encephalopathy - 23 seconds ago
- Actemra and Acute Myeloid Leukaemia Aggravated - 24 seconds ago
- Herceptin and Oropharyngeal Candidiasis - 31 seconds ago